{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T21:47:14Z","timestamp":1778276834476,"version":"3.51.4"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,10,22]],"date-time":"2020-10-22T00:00:00Z","timestamp":1603324800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,10,22]],"date-time":"2020-10-22T00:00:00Z","timestamp":1603324800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Nephrol"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1007\/s10157-020-01985-7","type":"journal-article","created":{"date-parts":[[2020,10,22]],"date-time":"2020-10-22T06:03:21Z","timestamp":1603346601000},"page":"240-250","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Adult-onset minimal change disease: the significance of histological chronic changes for clinical presentation and outcome"],"prefix":"10.1007","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7336-5874","authenticated-orcid":false,"given":"Gabriel","family":"Stefan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruxandra","family":"Busuioc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simona","family":"Stancu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madalina","family":"Hoinoiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrian","family":"Zugravu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicoleta","family":"Petre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriel","family":"Mircescu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,10,22]]},"reference":[{"issue":"9384","key":"1985_CR1","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S0140-6736(03)14184-0","volume":"362","author":"AA Eddy","year":"2003","unstructured":"Eddy AA, Symons JM. Nephrotic syndrome in childhood. Lancet. 2003;362(9384):629\u201339. https:\/\/doi.org\/10.1016\/S0140-6736(03)14184-0.","journal-title":"Lancet"},{"issue":"2","key":"1985_CR2","doi-asserted-by":"publisher","first-page":"332","DOI":"10.2215\/CJN.05000516","volume":"12","author":"M Vivarelli","year":"2017","unstructured":"Vivarelli M, Massella L, Ruggiero B, Emma F. Minimal change disease. Clin J Am Soc Nephrol. 2017;12(2):332\u201345. https:\/\/doi.org\/10.2215\/CJN.05000516.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"1985_CR3","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/s0272-6386(97)90485-6","volume":"30","author":"M Haas","year":"1997","unstructured":"Haas M, Meehan SM, Karrison TG, Spargo BH. Changing etiologies of unexplained adult nephrotic syndrome: a comparison of renal biopsy findings from 1976\u20131979 and 1995\u20131997. Am J Kidney Dis. 1997;30(5):621\u201331. https:\/\/doi.org\/10.1016\/s0272-6386(97)90485-6.","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"1985_CR4","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1053\/ajkd.2002.31400","volume":"39","author":"M Nakayama","year":"2002","unstructured":"Nakayama M, Katafuchi R, Yanase T, Ikeda K, Tanaka H, Fujimi S. Steroid responsiveness and frequency of relapse in adult-onset minimal change nephrotic syndrome. Am J Kidney Dis. 2002;39(3):503\u201312. https:\/\/doi.org\/10.1053\/ajkd.2002.31400.","journal-title":"Am J Kidney Dis"},{"issue":"11","key":"1985_CR5","doi-asserted-by":"publisher","first-page":"2192","DOI":"10.1093\/oxfordjournals.ndt.a027136","volume":"11","author":"SK Mak","year":"1996","unstructured":"Mak SK, Short CD, Mallick NP. Long-term outcome of adult-onset minimal-change nephropathy. Nephrol Dial Transplant. 1996;11(11):2192\u2013201. https:\/\/doi.org\/10.1093\/oxfordjournals.ndt.a027136.","journal-title":"Nephrol Dial Transplant"},{"issue":"7","key":"1985_CR6","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1093\/ndt\/gfg134","volume":"18","author":"KC Tse","year":"2003","unstructured":"Tse KC, Lam MF, Yip PS, Li FK, Choy BY, Lai KN, et al. Idiopathic minimal change nephrotic syndrome in older adults: steroid responsiveness and pattern of relapses. Nephrol Dial Transplant. 2003;18(7):1316\u201320. https:\/\/doi.org\/10.1093\/ndt\/gfg134.","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"1985_CR7","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/s0272-6386(12)80353-2","volume":"17","author":"S Fujimoto","year":"1991","unstructured":"Fujimoto S, Yamamoto Y, Hisanaga S, Morita S, Eto T, Tanaka K. Minimal change nephrotic syndrome in adults: response to corticosteroid therapy and frequency of relapse. Am J Kidney Dis. 1991;17(6):687\u201392. https:\/\/doi.org\/10.1016\/s0272-6386(12)80353-2.","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"1985_CR8","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1159\/000167603","volume":"8","author":"SM Korbet","year":"1988","unstructured":"Korbet SM, Schwartz MM, Lewis EJ. Minimal-change glomerulopathy of adulthood. Am J Nephrol. 1988;8(4):291\u20137. https:\/\/doi.org\/10.1159\/000167603.","journal-title":"Am J Nephrol"},{"issue":"3","key":"1985_CR9","doi-asserted-by":"publisher","first-page":"445","DOI":"10.2215\/CJN.03531006","volume":"2","author":"M Waldman","year":"2007","unstructured":"Waldman M, Crew RJ, Valeri A, Busch J, Stokes B, Markowitz G, et al. Adult minimal-change disease: clinical characteristics, treatment, and outcomes. Clin J Am Soc Nephrol. 2007;2(3):445\u201353. https:\/\/doi.org\/10.2215\/CJN.03531006.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"1985_CR10","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1053\/j.ajkd.2016.10.032","volume":"69","author":"RJ Maas","year":"2017","unstructured":"Maas RJ, Deegens JK, Beukhof JR, Reichert LJ, Ten Dam MA, Beutler JJ, et al. The clinical course of minimal change nephrotic syndrome with onset in adulthood or late adolescence: a case series. Am J Kidney Dis. 2017;69(5):637\u201346. https:\/\/doi.org\/10.1053\/j.ajkd.2016.10.032.","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"1985_CR11","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1186\/s12882-018-0999-x","volume":"19","author":"A Fenton","year":"2018","unstructured":"Fenton A, Smith SW, Hewins P. Adult minimal-change disease: observational data from a UK centre on patient characteristics, therapies, and outcomes. BMC Nephrol. 2018;19(1):207. https:\/\/doi.org\/10.1186\/s12882-018-0999-x.","journal-title":"BMC Nephrol"},{"issue":"3","key":"1985_CR12","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1038\/ki.1981.39","volume":"19","author":"NJ Siegel","year":"1981","unstructured":"Siegel NJ, Gaudio KM, Krassner LS, McDonald BM, Anderson FP, Kashgarian M. Steroid-dependent nephrotic syndrome in children: histopathology and relapses after cyclophosphamide treatment. Kidney Int. 1981;19(3):454\u20139. https:\/\/doi.org\/10.1038\/ki.1981.39.","journal-title":"Kidney Int"},{"key":"1985_CR13","first-page":"417","volume":"6","author":"R Habib","year":"1971","unstructured":"Habib R, Kleinknecht C. The primary nephrotic syndrome of childhood. Classification and clinicopathologic study of 406 cases. Pathol Annu. 1971;6:417\u201374.","journal-title":"Pathol Annu"},{"issue":"5","key":"1985_CR14","first-page":"171","volume":"10","author":"R Waldherr","year":"1978","unstructured":"Waldherr R, Gubler MC, Levy M, Broyer M, Habib R. The significance of pure diffuse mesangial proliferation in idiopathic nephrotic syndrome. Clin Nephrol. 1978;10(5):171\u20139.","journal-title":"Clin Nephrol"},{"issue":"5","key":"1985_CR15","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.kint.2018.04.024","volume":"94","author":"A Meyrier","year":"2018","unstructured":"Meyrier A, Niaudet P. Acute kidney injury complicating nephrotic syndrome of minimal change disease. Kidney Int. 2018;94(5):861\u20139. https:\/\/doi.org\/10.1016\/j.kint.2018.04.024.","journal-title":"Kidney Int"},{"issue":"2","key":"1985_CR16","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1093\/ndt\/gfy220","volume":"34","author":"S Sethi","year":"2019","unstructured":"Sethi S, Fervenza FC. Standardized classification and reporting of glomerulonephritis. Nephrol Dial Transplant. 2019;34(2):193\u20139. https:\/\/doi.org\/10.1093\/ndt\/gfy220.","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"1985_CR17","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.kint.2017.01.002","volume":"91","author":"S Sethi","year":"2017","unstructured":"Sethi S, D\u2019Agati VD, Nast CC, Fogo AB, De Vriese AS, Markowitz GS, et al. A proposal for standardized grading of chronic changes in native kidney biopsy specimens. Kidney Int. 2017;91(4):787\u20139. https:\/\/doi.org\/10.1016\/j.kint.2017.01.002.","journal-title":"Kidney Int"},{"key":"1985_CR18","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney inter, Suppl. 2012;2:1\u2013138."},{"issue":"5","key":"1985_CR19","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1681\/ASN.2015060612","volume":"27","author":"S Sethi","year":"2016","unstructured":"Sethi S, Haas M, Markowitz GS, D\u2019Agati VD, Rennke HG, Jennette JC, et al. Mayo clinic\/renal pathology society consensus report on pathologic classification, diagnosis, and reporting of GN. J Am Soc Nephrol. 2016;27(5):1278\u201387. https:\/\/doi.org\/10.1681\/ASN.2015060612.","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"1985_CR20","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1053\/j.ajkd.2014.09.022","volume":"65","author":"CC Szeto","year":"2015","unstructured":"Szeto CC, Lai FM, Chow KM, Kwan BC, Kwong VW, Leung CB, et al. Long-term outcome of biopsy-proven minimal change nephropathy in Chinese adults. Am J Kidney Dis. 2015;65(5):710\u20138. https:\/\/doi.org\/10.1053\/j.ajkd.2014.09.022.","journal-title":"Am J Kidney Dis"},{"key":"1985_CR21","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2019.12.019","author":"W Ahn","year":"2020","unstructured":"Ahn W, Bomback AS. Approach to diagnosis and management of primary glomerular diseases due to podocytopathies in adults: Core Curriculum 2020. Am J Kidney Dis. 2020. https:\/\/doi.org\/10.1053\/j.ajkd.2019.12.019.","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"1985_CR22","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/j.kint.2017.10.022","volume":"93","author":"AS Bomback","year":"2018","unstructured":"Bomback AS, Santoriello D, Avasare RS, Regunathan-Shenk R, Canetta PA, Ahn W, et al. C3 glomerulonephritis and dense deposit disease share a similar disease course in a large United States cohort of patients with C3 glomerulopathy. Kidney Int. 2018;93(4):977\u201385. https:\/\/doi.org\/10.1016\/j.kint.2017.10.022.","journal-title":"Kidney Int"},{"key":"1985_CR23","doi-asserted-by":"publisher","unstructured":"Smith J, Stevens K, Mackinnon B, Methven S, Kidder D. FP203THE prognostic utility of renal biopsy chronicity scoring in ANCA associated glomerulonephritis. Nephrology Dialysis Transplantation. 2019;34(Supplement_1). doi:https:\/\/doi.org\/10.1093\/ndt\/gfz106.FP203.","DOI":"10.1093\/ndt\/gfz106.FP203"},{"issue":"1","key":"1985_CR24","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/ki.1983.129","volume":"24","author":"RJ Hogg","year":"1983","unstructured":"Hogg RJ. Childhood nephrotic syndrome associated with diffuse mesangial hypercellularity. A report of the Southwest Pediatric Nephrology Study Group. Kidney Int. 1983;24(1):87\u201394. https:\/\/doi.org\/10.1038\/ki.1983.129.","journal-title":"Kidney Int"},{"issue":"6","key":"1985_CR25","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1038\/ki.1981.209","volume":"20","author":"HL Barnett","year":"1981","unstructured":"Barnett HL, Edelmann CM, Greifer I. Primary nephrotic syndrome in children: clinical significance of histopathologic variants of minimal change and of diffuse mesangial hypercellularity. A Report of the International Study of Kidney Disease in Children. Kidney Int. 1981;20(6):765\u201371. https:\/\/doi.org\/10.1038\/ki.1981.209.","journal-title":"Kidney Int"},{"issue":"5720","key":"1985_CR26","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1136\/bmj.3.5720.421","volume":"3","author":"DA Black","year":"1970","unstructured":"Black DA, Rose G, Brewer DB. Controlled trial of prednisone in adult patients with the nephrotic syndrome. Br Med J. 1970;3(5720):421\u20136. https:\/\/doi.org\/10.1136\/bmj.3.5720.421.","journal-title":"Br Med J"},{"key":"1985_CR27","first-page":"18","volume":"97","author":"CH Coggins","year":"1986","unstructured":"Coggins CH. Adult minimal change nephropathy: the experience of the collaborative study of glomerular disease. Trans Am Clin Climatol Assoc. 1986;97:18\u201326.","journal-title":"Trans Am Clin Climatol Assoc"},{"issue":"2","key":"1985_CR28","doi-asserted-by":"publisher","first-page":"209","DOI":"10.2215\/CJN.06180519","volume":"15","author":"NR Medjeral-Thomas","year":"2020","unstructured":"Medjeral-Thomas NR, Lawrence C, Condon M, Sood B, Warwicker P, Brown H, et al. Randomized, controlled trial of tacrolimus and prednisolone monotherapy for adults with de novo minimal change disease: a multicenter, randomized, controlled trial. Clin J Am Soc Nephrol. 2020;15(2):209\u201318. https:\/\/doi.org\/10.2215\/CJN.06180519.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"17","key":"1985_CR29","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.2169\/internalmedicine.54.3927","volume":"54","author":"L Zhao","year":"2015","unstructured":"Zhao L, Cheng J, Zhou J, Wu C, Chen J. Enhanced steroid therapy in adult minimal change nephrotic syndrome: a systematic review and meta-analysis. Intern Med. 2015;54(17):2101\u20138. https:\/\/doi.org\/10.2169\/internalmedicine.54.3927.","journal-title":"Intern Med"},{"issue":"5","key":"1985_CR30","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1093\/ckj\/sft063","volume":"6","author":"V Keskar","year":"2013","unstructured":"Keskar V, Jamale TE, Kulkarni MJ, Kiggal Jagadish P, Fernandes G, Hase N. Minimal-change disease in adolescents and adults: epidemiology and therapeutic response. Clin Kidney J. 2013;6(5):469\u201372. https:\/\/doi.org\/10.1093\/ckj\/sft063.","journal-title":"Clin Kidney J"},{"issue":"1","key":"1985_CR31","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/s0272-6386(12)70179-8","volume":"22","author":"J Radhakrishnan","year":"1993","unstructured":"Radhakrishnan J, Appel AS, Valeri A, Appel GB. The nephrotic syndrome, lipids, and risk factors for cardiovascular disease. Am J Kidney Dis. 1993;22(1):135\u201342. https:\/\/doi.org\/10.1016\/s0272-6386(12)70179-8.","journal-title":"Am J Kidney Dis"},{"issue":"12","key":"1985_CR32","doi-asserted-by":"publisher","first-page":"e3179","DOI":"10.1097\/MD.0000000000003179","volume":"95","author":"H Lee","year":"2016","unstructured":"Lee H, Yoo KD, Oh YK, Kim DK, Oh KH, Joo KW, et al. Predictors of relapse in adult-onset nephrotic minimal change disease. Medicine (Baltimore). 2016;95(12):e3179. https:\/\/doi.org\/10.1097\/MD.0000000000003179.","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"1985_CR33","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1053\/j.ajkd.2005.02.007","volume":"45","author":"CL Chen","year":"2005","unstructured":"Chen CL, Fang HC, Chou KJ, Lee JC, Lee PT, Chung HM, et al. Increased endothelin 1 expression in adult-onset minimal change nephropathy with acute renal failure. Am J Kidney Dis. 2005;45(5):818\u201325. https:\/\/doi.org\/10.1053\/j.ajkd.2005.02.007.","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"1985_CR34","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1038\/ki.1986.130","volume":"29","author":"F Nolasco","year":"1986","unstructured":"Nolasco F, Cameron JS, Heywood EF, Hicks J, Ogg C, Williams DG. Adult-onset minimal change nephrotic syndrome: a long-term follow-up. Kidney Int. 1986;29(6):1215\u201323. https:\/\/doi.org\/10.1038\/ki.1986.130.","journal-title":"Kidney Int"},{"issue":"6","key":"1985_CR35","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1007\/s10157-020-01864-1","volume":"24","author":"R Yamamoto","year":"2020","unstructured":"Yamamoto R, Imai E, Maruyama S, Yokoyama H, Sugiyama H, Nitta K, et al. Incidence of remission and relapse of proteinuria, end-stage kidney disease, mortality, and major outcomes in primary nephrotic syndrome: the Japan Nephrotic Syndrome Cohort Study (JNSCS). Clin Exp Nephrol. 2020;24(6):526\u201340. https:\/\/doi.org\/10.1007\/s10157-020-01864-1.","journal-title":"Clin Exp Nephrol"}],"container-title":["Clinical and Experimental Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-020-01985-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10157-020-01985-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-020-01985-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,22]],"date-time":"2021-10-22T00:09:56Z","timestamp":1634861396000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10157-020-01985-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,22]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["1985"],"URL":"https:\/\/doi.org\/10.1007\/s10157-020-01985-7","relation":{},"ISSN":["1342-1751","1437-7799"],"issn-type":[{"value":"1342-1751","type":"print"},{"value":"1437-7799","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,22]]},"assertion":[{"value":"24 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no conflicts of interest or competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by the institutional review board of Dr Carol Davila Teaching Hospital of Nephrology, Bucharest, Romania (approval number 2020-010).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical statement"}},{"value":"Informed consent was not required in view of the retrospective study design and the anonymity of the patient records reviewed.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}